Talcum Powder Lawsuit (2026): Claims, Status & Who May Qualify

Talcum powder lawsuits allege that long-term use of talc-based products, primarily Johnson's Baby Powder and similar cosmetic powders, is linked to ovarian cancer and mesothelioma, often through asbestos that can occur naturally near talc. Tens of thousands of these claims are consolidated in active federal litigation, and on July 27, 2026, Johnson & Johnson announced a proposed $5.5 billion settlement of the ovarian-cancer claims that is not yet final.

This page is part of our Mass Tort & Product Liability overview.

What talcum powder is and the alleged harm

Talc is a naturally occurring mineral used in cosmetic powders for its ability to absorb moisture and reduce friction, which is why it has long appeared in baby powder, body and face powders, and similar products. The legal claims arise from two distinct theories. First, plaintiffs allege that genital (perineal) use of talc-based powder over many years contributed to ovarian cancer. Second, plaintiffs allege that some talc was contaminated with asbestos, a known carcinogen that can occur in the same geological deposits as talc, and that breathing or otherwise being exposed to that asbestos caused mesothelioma, a rare and aggressive cancer of the tissue lining the lungs and abdomen. The most-named product is Johnson's Baby Powder, but the litigation involves other talc-based cosmetics as well. These are allegations being tested in court, not findings that any product caused any individual's illness.

Note: A lawsuit alleging a link is not the same as a court or agency finding that talc caused a specific person's cancer. Causation in each case is contested and must be proven with evidence.

What the science and regulators say

The scientific and regulatory picture is genuinely mixed, and careful language matters here. The National Cancer Institute's prevention summary states that results from case-control and cohort studies are inconsistent, so the data are inadequate to support an association between perineal talc exposure and an increased risk of ovarian cancer. Some meta-analyses have reported a modest association (for example, a relative risk of about 1.33), while large prospective cohort studies such as the Nurses' Health Study found no statistically significant increase, and a clear dose-response relationship was not established. The asbestos theory rests on firmer ground: the National Cancer Institute notes that asbestos is classified as a known human carcinogen by HHS, the EPA, and the International Agency for Research on Cancer, with sufficient evidence linking it to mesothelioma and ovarian cancer. On the regulatory side, in October 2019 Johnson & Johnson voluntarily recalled a single lot of Johnson's Baby Powder after FDA testing found sub-trace levels of chrysotile asbestos in a sample. In December 2024 the FDA proposed a rule under the Modernization of Cosmetics Regulation Act to standardize asbestos testing in talc-containing cosmetics, though the agency later withdrew that proposal pending further review.

The status of the talcum powder litigation (as of August 2026)

Most federal ovarian-cancer talc claims are consolidated for pretrial proceedings in multidistrict litigation, In re Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation, MDL No. 2738, before Judge Michael A. Shipp in the U.S. District Court for the District of New Jersey. According to the Judicial Panel on Multidistrict Litigation's statistics report dated August 3, 2026, MDL No. 2738 had about 68,914 actions pending, making it the largest active MDL in the federal system. Mesothelioma claims involving talc are frequently litigated separately in state courts. On July 27, 2026, Johnson & Johnson announced a proposed resolution of the remaining ovarian-cancer talc claims: a commitment of $5.5 billion paid over several years, with the first payment capped at $3 billion and due in 2027. The proposal is an opt-in claims-resolution structure negotiated with plaintiffs' law firms, it is contingent on at least 95 percent of the remaining claimants participating, and it does not cover mesothelioma claims. It followed the courts' rejection of Johnson & Johnson's repeated attempts to resolve the talc liability through a subsidiary's bankruptcy. As of mid-August 2026 the settlement is proposed, not final, and no claims facility or payment process is open. Litigation status, verdicts, and settlement terms change frequently.

Note: MDL case counts, bellwether schedules, and any settlement developments change over time. Treat the figures here as a snapshot as of August 2026 and check current court records for the latest status.

Who may be involved

The people generally involved in talc litigation fall into a few broad categories, described here neutrally rather than as a promise that anyone qualifies. The ovarian-cancer claims typically involve women who used talc-based powders in the genital area regularly and over a span of years before an ovarian cancer diagnosis. The mesothelioma claims typically involve people diagnosed with mesothelioma who used or were exposed to talc products and allege that asbestos contamination was the source, sometimes in addition to other possible asbestos exposures. Family members of someone who died from these conditions may also be involved through wrongful-death or survival claims, depending on state law. Whether any particular person has a viable claim depends on the specific facts, including the diagnosis, the documented product use, the timeline, and the applicable state law.

Deadlines and why they matter

Every state sets its own statute of limitations, the legal time limit for filing a personal-injury or wrongful-death lawsuit. These deadlines vary widely from state to state and are often measured from the date of diagnosis or, under some states' discovery rules, from when a person knew or reasonably should have known that an injury may be connected to a product. Because the limits differ and the trigger date can be disputed, there is no single national deadline that applies to everyone, and this page does not and cannot tell you what your specific deadline is. Missing the applicable deadline can permanently bar a claim regardless of its underlying merit, which is why people who believe they may be affected often consult a licensed attorney promptly rather than waiting.

How to evaluate your options

The most reliable way to understand whether you may have a claim is to speak with an attorney licensed in your state, because the analysis turns on the facts and on state law that general information cannot resolve. It can help to gather records before that conversation, including medical records and the pathology report confirming the diagnosis, any documentation or recollection of which talc products were used and for how long, and proof of purchase where it exists. Most attorneys who handle mass-tort cases offer a free initial consultation and work on a contingency-fee basis, meaning they are paid a percentage only if the case results in a recovery, so an evaluation typically creates no obligation and no upfront cost. A consultation is informational; it is not a guarantee of eligibility, compensation, or any particular outcome.